Neonatal hyperbilirubinemia (neonatal jaundice) occurs in more than 60% of term newborns and is characterized by a peak of bilirubin between the 3-5th day of life, returning to normal values in about 2 weeks.
In some cases, high levels of bilirubin in the blood are not solved within 2 weeks, leading to severe hyperbilirubinemia in about 10% of the jaundice infants.
The consequence of an excessive presence of bilirubin is the development of Kernicterus, a chronic and irreversible pathology characterized by a severe motor, hearing and intellectual deficit.
This creates the need for a system able to control the level of bilirubin during the first days after birth that should be simple to use, quick, inexpensive and usable anywhere, even outside the hospital structures.
Our solution, effective and portable
Bilistick ® System is an innovative low cost diagnostic device, conceived as a Point of Care system for measuring Total Bilirubin concentration in whole blood samples from newborns. The system consists of a test strip, where a small amount of blood is loaded, and a reader to get the result.
Thanks to the simplicity of the method, the small size of the system and the use of a battery powered reader, the use of Bilistick® does not require
availability of highly qualified staff and/or equipped facilities for analysis, making diagnosis and monitoring of neonatal jaundice a simple practice also outside of hospital facilities, such as during home follow up of neonates or in physician offices.
Moreover, thanks to this peculiar features it could also be used in screening projects in developing countries.